VisOptics cap.gl. 0.05% fl-cap 15ml
Category
Allergy
Scope of the drug
Eyes
Release form
Drops
Manufacturer country
Romania
Package quantity, pcs
one
Dosage form
Eye drops 0.05% in the form of a transparent colorless solution.
Structure
tetrizoline hydrochloride 500 mcg
Excipients: boric acid, sodium tetraborate decahydrate, disodium edetate dihydrate, benzalkonium chloride, purified water.
pharmachologic effect
Alpha adrenergic agonist.
It has a vasoconstrictor and anti-edema effect.
When applied topically, it reduces conjunctival edema, burning sensations, soreness of the mucous membrane of the eyes, lacrimation.
The vasoconstrictor effect develops within a few minutes and lasts 4-8 hours.
Pharmacokinetics
When applied topically, systemic absorption is low.
Side effects
Local reactions: increased intraocular pressure, burning sensation and reactive hyperemia of the eye
rarely - pupil dilation.
Systemic reactions: increased blood pressure, hyperglycemia, cardiac dysfunction, headache, nausea, drowsiness, weakness, tremor, dizziness, insomnia, tachycardia, allergic reactions.
Selling features
Available without a prescription
Special conditions
It is advisable to use VisOptics only for mild eye irritation.
If irritation and hyperemia of the conjunctiva are associated with an infectious disease, the presence of a foreign body or chemical trauma to the cornea, an ophthalmologist's consultation is necessary.
If, within 48 hours after the start of the use of eye drops, the symptoms of the disease persist, become more pronounced or side effects appear, the use of the drug should be discontinued and an ophthalmologist should be consulted.
In case of intense eye pain, headache, blurred vision, sudden appearance of floating spots" in front of the eyes, redness of the eyes, pain when exposed to light or double vision, you should immediately consult a doctor.
When wearing contact lenses, they are removed before instilling the drug and re-installed 15 minutes after it.
It is necessary to avoid direct contact of eye drops with soft contact lenses due to the possible violation of their transparency.
The drug should not be used concurrently with MAO inhibitors (including phenelzine, nialamide, iproniazide) and within 10 days after stopping them.
Influence on the ability to drive vehicles and use mechanisms
During the treatment period, care must be taken when driving vehicles and engaging in other potentially hazardous activities that require increased concentration of attention, speed of psychomotor reactions and good vision (after using eye drops, pupil dilation and a feeling of blurred vision are possible).
Indications
- moderate eye irritation: itching, edema and hyperemia of the conjunctiva, burning, lacrimation, injection of the sclera caused by chemical and physical factors (dust, cosmetics, swimming in chlorinated water, exposure to bright light or radiation from a computer monitor)
- allergic conjunctivitis.
Contraindications
- glaucoma
- endothelial-epithelial corneal dystrophy
- acute cardiovascular failure
- bacterial eye infection
- foreign body of the eye
- children under 3 years old
- hypersensitivity to drug components.
The drug should be used with caution in arterial hypertension, arrhythmias, aneurysm, hyperthyroidism, pheochromocytoma, diabetes mellitus, severe organic diseases of the heart and blood vessels (including ischemic heart disease), as well as during treatment with MAO inhibitors and other drugs that increase blood pressure.
Drug interactions
Concomitant use with MAO inhibitors, tricyclic antidepressants, guanethidine can cause hypertension, tachycardia.
Concomitant use with rezepine, insulin, propranolol, agents for general anesthesia, atropine increases the risk of cardiovascular effects of tetrizoline.
Simultaneous use with guanethidine
Name ENG
VIZOPTIK
Clinical and pharmacological group
Topical vasoconstrictor in ophthalmology (alpha-adrenergic agonist)
ATX code
Tetryzoline
Dosage
0.05% x 15ml
Structure
tetrizoline hydrochloride 500 mcg.
Excipients: boric acid, sodium tetraborate decahydrate, disodium edetate dihydrate, benzalkonium chloride, purified water.
Indications
moderate eye irritation: itching, swelling and hyperemia of the conjunctiva, burning, lacrimation, injection of the sclera caused by chemical and physical factors (dust, cosmetics, swimming in chlorinated water, exposure to bright light or radiation from a computer monitor)
allergic conjunctivitis.
Storage conditions and periods
At a temperature not exceeding 25 degrees, in the original packaging.
Expiration date: 5 years
INN / Active ingredient
tetrizoline hydrochloride
Contraindications
glaucoma
, endothelial-epithelial corneal dystrophy
, acute cardiovascular failure
, bacterial eye infection
, foreign body of the eye
, children under 3 years old
, hypersensitivity to drug components.
, The drug should be used with caution in arterial hypertension, arrhythmias, aneurysm, hyperthyroidism, pheochromocytoma, diabetes mellitus, severe organic diseases of the heart and blood vessels (including coronary heart disease), as well as during treatment with MAO inhibitors and other drugs that increase blood pressure ...
Specifications
Category
Allergy
Scope of the drug
Eyes
Release form
Drops
Manufacturer country
Romania
Package quantity, pcs
one
Scope of application
Ophthalmology
Minimum age from
3 years old
Way of introduction
Into the conjunctival sac
Vacation conditions
Without recipe
Volume, ml.
15 ml
Brand name
SC ROMPHARM
The amount of the dosage form in the primary package
15 ml
Primary packaging type
Dropper bottle
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Alpha adrenomimetic
Anatomical and therapeutic characteristics
S01GA02 Tetrizolin
Dosage form
Eye drops
Dosage (volume) of the substance in the preparation
Tetrizoline hydrochloride 500 mcg
Expiration date in days
1825
The target audience
Children
Package weight, g
twenty
Mode of application
:
Adults and children over 3 years old are instilled 1-2 drops of 2-3 into the lower conjunctival sac of the affected eye.
Shelf life after opening
:
After opening the bottle, the drops should be used within 4 weeks.
Information on technical characteristics, delivery set, country of manufacture "